S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%
Next Bullish Trade
Sign in
COR

Cencora, Inc. COR

$307.90 -0.09 (-0.03%)
Extended · +1.60σ
Mkt cap $59.6B
P/E 23.5
Day $306.41 – $313.90
52wk $244.82 – $376.92
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

Cencora, Inc. is a healthcare company listed in the US.

COR last traded at $307.90, down 0.0% on the day; that's in the middle part of its 52-week range ($244.82–$376.92). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 64), the trend is strong (ADX 28), and volume is about normal (1.4×). On the business side, revenue is growing 4% year over year and the business keeps about -0 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
64
0–100 · <30 oversold
Trend strength · ADX
28
>25 = strong trend
Volume vs avg
1.43×
1× = average
Stretch from avg
+1.5 ATR
− below · + above
Zone touches
0
tests of this zone
Suggested hold
3–30
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth
+3.8%
year over year
Free-cash-flow margin
-0.1%
cash kept per $ of sales
Debt / equity
4.21
lower = less leveraged
P/E ratio
23.5
price ÷ yearly profit

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Fair-value range
$234.90 – $4954.73
Verdict
Unknown
Accounting quality Weak
  • ✓ Positive retained earnings
  • ⚠ Debt exceeds cash
  • ⚠ Quick ratio 0.47 (fragile)
  • ⚠ Debt/equity 49.63 (fragile)

Key statistics

All statistics →

COR is a $59.6 billion company, priced at 24× last year's earnings.

Mkt cap $59.6B
P/E ttm 23.5
Fwd P/E
Beta
Day range $306.41 – $313.90
52w range $244.82 – $376.92
Avg vol
RSI(2) 73.9
ROE
Net mgn
FCF mgn -0.1%
Debt/Eq 4.21
Div yld
Sector Healthcare
Industry Medical Distribution
Next earn
52-week range · today's price
$244.82$376.92

More on COR